|
Market Closed -
Nasdaq
00:00:00 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.850 USD | -10.19% |
|
-3.65% | -74.86% |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Chart: Technical Analysis
Stock exchange
Nasdaq
KPTI 1.850 $
-10.19%
2.96M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| KPTI | 1.850USD | -10.19% | 2.96M $ | |
CBOE
| KPTI | 1.855USD | -10.60% | 86.19K $ | |
|
Tradegate
| 25K0 | 1.610EUR | -9.55% | 3.1K € | |
|
Deutsche Boerse AG
| 25K0 | 1.570EUR | -3.09% | 0 € | |
|
Börse Stuttgart
| 25K0 | 1.590EUR | 0.00% | 0 € | |
|
Boerse Muenchen
| 25K0 | 1.610EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 3.77 | 4.23 | 4.55 |
| Spread/Res. | -50.93% | -56.26% | -59.34% |
| Spread/Supp. | +2.21% | +2.21% | +88.95% |
| Support | 1.81 | 1.81 | 0.9791 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KPTI Stock
- Charts Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
